Regenerative Medical Solutions

About:

Regenerative Medical Solutions is a biotechnology company developing regenerative medical products used to treat diabetes.

Website: http://www.regenmedsolutions.com

Description:

Regenerative Medical Solutions is a developer of regenerative medical products used to treat diabetes. The company offers ProgenMix, a media formulation that generates pancreatic progenitor cells and endocrine cell types; works with multiple human ESC and iPSC lines; and operates as a platform for drug testing and assay development. It also provides consulting services; and engages in developing treatments and applications for diabetes patients. The company’s ProgenMix is used in various applications ranging from scientific research to testing the potential toxicity of candidate drugs.

Total Funding Amount:

$6.48M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Madison, Wisconsin, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)regenmedsolutions.com

Founders:

Anthony D. Kolton, Gary Gorman, Jon S. Odorico

Number of Employees:

1-10

Last Funding Date:

2023-08-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai